These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 1850009)

  • 1. Pathways of activation of the Epstein-Barr virus productive cycle.
    Sinclair AJ; Brimmell M; Shanahan F; Farrell PJ
    J Virol; 1991 May; 65(5):2237-44. PubMed ID: 1850009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Zif268 cellular transcription factor activates expression of the Epstein-Barr virus immediate-early BRLF1 promoter.
    Zalani S; Holley-Guthrie E; Kenney S
    J Virol; 1995 Jun; 69(6):3816-23. PubMed ID: 7745729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the epstein-barr virus BRRF1 gene, located between early genes BZLF1 and BRLF1.
    Segouffin-Cariou C; Farjot G; Sergeant A; Gruffat H
    J Gen Virol; 2000 Jul; 81(Pt 7):1791-9. PubMed ID: 10859385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
    Le Roux F; Sergeant A; Corbo L
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBV-immortalized isogenic human B-cell clones exhibit differences in DNA-protein complex formation on the BZLF1 and BRLF1 promoter regions among latent, lytic and TPA-activated cell lines.
    Cen H; McKnight JL
    Virus Res; 1994 Jan; 31(1):89-107. PubMed ID: 8165871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.
    Jung YJ; Choi H; Kim H; Lee SK
    J Virol; 2014 Aug; 88(16):9027-37. PubMed ID: 24899173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
    Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
    J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.
    Quinlivan EB; Holley-Guthrie EA; Norris M; Gutsch D; Bachenheimer SL; Kenney SC
    Nucleic Acids Res; 1993 Jul; 21(14):1999-2007. PubMed ID: 8393562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor.
    Zalani S; Holley-Guthrie EA; Gutsch DE; Kenney SC
    J Virol; 1992 Dec; 66(12):7282-92. PubMed ID: 1331521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic autoactivation of the Epstein-Barr virus immediate-early BRLF1 promoter by Rta and Zta.
    Liu P; Speck SH
    Virology; 2003 Jun; 310(2):199-206. PubMed ID: 12781707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation.
    Chang LK; Liu ST
    Nucleic Acids Res; 2000 Oct; 28(20):3918-25. PubMed ID: 11024171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain variation in Epstein-Barr virus immediate early genes.
    Packham G; Brimmell M; Cook D; Sinclair AJ; Farrell PJ
    Virology; 1993 Feb; 192(2):541-50. PubMed ID: 8093650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
    Ye J; Gradoville L; Daigle D; Miller G
    J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.
    Hergenhahn M; Soto U; Weninger A; Polack A; Hsu CH; Cheng AL; Rösl F
    Mol Carcinog; 2002 Mar; 33(3):137-45. PubMed ID: 11870879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.
    Wille CK; Nawandar DM; Panfil AR; Ko MM; Hagemeier SR; Kenney SC
    J Virol; 2013 Jan; 87(2):935-50. PubMed ID: 23135711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.
    Fahmi H; Cochet C; Hmama Z; Opolon P; Joab I
    J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone acetylation and reactivation of Epstein-Barr virus from latency.
    Jenkins PJ; Binné UK; Farrell PJ
    J Virol; 2000 Jan; 74(2):710-20. PubMed ID: 10623733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus BZLF1 transactivator is a negative regulator of Jun.
    Sato H; Takeshita H; Furukawa M; Seiki M
    J Virol; 1992 Aug; 66(8):4732-6. PubMed ID: 1321269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F.
    Liu C; Sista ND; Pagano JS
    J Virol; 1996 Apr; 70(4):2545-55. PubMed ID: 8642684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
    Gradoville L; Kwa D; El-Guindy A; Miller G
    J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.